Yankees Score with ...
Health Care: Health Services
WuXi PharmaTech (Cayman) Inc. (WX: NYSE)
$20.48 -0.41 | -1.96%
05/24/13 - 04:01 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 86.58M | 80.98M | 90.81M | 52.87M |
| Operating Gains/Losses | 1.28M | 1.36M | -874.00K | -1.49M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -27.31M | -14.40M | -11.50M | -10.62M |
| (Increase) Decrease in Inventories | -3.18M | -26.81M | -2.82M | -7.75M |
| (Increase) Decrease In Other Current Assets | 1.25M | -332.00K | -3.74M | 1.32M |
| (Decrease) Increase In Payables | 1.63M | 5.02M | 1.95M | -905.00K |
| (Decrease) Increase In Other Current Liabilities | 13.82M | -2.03M | 9.21M | 2.39M |
| (Increase) Decrease In Other Working Capital | 1.34M | 8.80M | 3.04M | 6.00K |
| Other Non-Cash Items | 13.96M | 14.47M | 10.37M | 13.18M |
| Net Cash From Continuing Operations | 131.06M | 101.06M | 125.65M | 69.77M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 131.06M | 101.06M | 125.65M | 69.77M |
| Sale of Property, Plant & Equipment | 69.00K | 77.00K | 28.00K | 7.00K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 259.28M | 196.16M | 103.40M | 46.84M |
| Purchases of Property, Plant & Equipment | -63.06M | -76.72M | -49.42M | -55.26M |
| Acquisitions | 0.00 | -12.56M | 0.00 | -13.50M |
| Purchases of Short-Term Investments | -305.58M | -280.77M | -118.18M | -54.16M |
| Other Cash from Investing Activities | 2.03M | -396.00K | 2.36M | 2.30M |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -117.58M | -178.53M | -61.80M | -73.78M |
| Issuance of Debt | 81.50M | 55.95M | 0.00 | 86.44M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 1.38M | 1.64M | 2.36M | 1.42M |
| Repayment of Long-Term Debt | -47.12M | -27.82M | -34.62M | -59.88M |
| Repurchase of Capital Stock | -67.00M | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | -1.00K |
| Net Cash From Financing Activities | -31.24M | 29.77M | -32.26M | 27.98M |
| Effect of Exchange Rate Changes | 526.00K | 3.66M | 3.30M | -94.00K |
| Net Change in Cash & Cash Equivalents | -17.24M | -44.03M | 34.89M | 23.89M |
Portfolios with WX
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ProJulian Robertson - Tiger Ma...
- ContributorStocks Rising On Unusual Vo...
- Contributor8 Biotech Stocks to Watch
- Contributor10 Health Care Stocks With ...
- Contributor10 Pharma Stocks With Upside
- Contributor5 Drug Stocks With Upside P...
- UserAberian Systems - Internati...
- UserTrading Stocks - Recommenda...
Latest WX Headlines from TheStreet
- 4 Stocks Rising on Unusual Volume 04.15.13 | 02:04 pm
- 4 Stocks Pushing The Health Services Industry Higher 11.30.12 | 12:11 pm
- WuXi PharmaTech (Cayman) Management Discusses Q2 2012 Results - Earnings Call Transcript 08.14.12 | 01:08 pm
- Can Netflix Stay Afloat? 07.16.12 | 06:07 am
- WuXi PharmaTech (Cayman) Inc. Stock Upgraded (WX) 02.01.12 | 05:02 am
- WuXi PharmaTech (Cayman Stock Hits New 52-Week Low (WX) 12.12.11 | 10:12 am
- WuXi PharmaTech (Cayman Stock Hits New 52-Week Low (WX) 10.07.11 | 02:10 pm
- WuXi PharmaTech (Cayman) Inc. Stock Downgraded (WX) 10.06.11 | 07:10 am
- 8 Biotech Stocks to Watch 09.07.11 | 11:09 am
- WuXi PharmaTech (Cayman Reaches New 52-Week High (WX) 05.16.11 | 11:05 am
Press Releases for WX
- WuXi PharmaTech Files 2012 Annual Report On Form 20-F - PR Newswire 04.17.13 | 09:04 am
- Chinese Premier Li Keqiang Visits WuXi PharmaTech's Headquarter In Shanghai - PR Newswire 04.01.13 | 07:04 am
- WuXi PharmaTech Receives Letter From AAALAC Commending Animal Care At Suzhou Toxicology Facility As "Exemplary" - PR Newswire 03.13.13 | 09:03 am
- WuXi PharmaTech And Open Monoclonal Technology Expand Human Antibody Development And Commercial Opportunities For Asian Regional And Global Pharmaceutical Companies - PR Newswire 03.05.13 | 08:03 am
- WuXi PharmaTech Presents The 2012 Life Science And Chemistry Awards - PR Newswire 01.30.13 | 03:01 pm
- WuXi PharmaTech Provides Update Of 2012 Financial Guidance, To Present At J.P. Morgan Healthcare Conference - PR Newswire 01.07.13 | 08:01 am
- WuXi PharmaTech And PRA Form Joint Venture To Offer Clinical Research Services For Chinese Market - PR Newswire 12.18.12 | 04:12 pm
- MedImmune And WuXi AppTec Announce Joint Venture To Develop Novel Biologic For Chinese Market - PR Newswire 09.10.12 | 01:09 pm
- WuXi PharmaTech Celebrates Dr. Joseph Vacca's Induction Into American Chemical Society's Medicinal Chemistry Hall Of Fame - PR Newswire 09.04.12 | 04:09 pm
- WuXi PharmaTech And Open Monoclonal Technology Announce OmniRat(TM) Antibody Collaboration - PR Newswire 09.04.12 | 08:09 am
Partner Headlines for WX
- WuXi PharmaTech Earnings: Everything You Must Know Now - Wall St. Cheat Sheet 05.14.13 | 09:05 am
- Stocks Weaken In Late Trade; Qihoo, YY Slide - Investor's Business Daily 05.13.13 | 03:05 pm
- Parexel International Leads Medical Research Group - Investor's Business Daily 11.16.12 | 06:11 pm
- WuXi, Regeneron In Buying Range Despite Market's Woes - Investor's Business Daily 11.15.12 | 04:11 pm
- Pfizer-Hisun JV Launched - Analyst Blog - Zacks 09.18.12 | 09:09 am
- AstraZeneca in Neutral Lane - Analyst Blog - NASDAQ 09.14.12 | 09:09 pm
- AZN Unveils Bond Issue Pricing - Analyst Blog - NASDAQ 09.12.12 | 08:09 pm
- AstraZeneca and WuXi Join Forces - Analyst Blog - NASDAQ 09.11.12 | 09:09 pm
- UPDATE: Deutsche Bank Raises WuXi PharmaTech's PT - Benzinga 05.14.12 | 09:05 am
- Oppenheimer Reiterates Outperform Rating, $22 PT for WuXi PharmaTech - Benzinga 05.11.12 | 09:05 pm
